Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
10.1074/jbc.R111.283432 J
The drugmaker just released its latest data from its phase 3 trials of retatrutide and its showing encouraging results
The TGA said it was continuing to monitor signals linked to harmful unregistered medicines and is working with the Australian Border Force to intercept, seize and destroy counterfeit products entering the country
Cardiovascular and kidney outcomes Semaglutide has impressive cardiovascular data, but again, indications differ: In SUSTAIN-6 and related trials, once-weekly semaglutide (as Ozempic) reduced major adverse cardiovascular events (MACE) in people with type 2 diabetes and established cardiovascular disease
Although NICE have accepted that there is a need for a Guideline they havent yet commissioned it into their workstream
As of 2025, more than 34 million people (over 54% of Medicare beneficiaries) are in Medicare Advantage, reflecting its growing popularity
US$ 25.27
US$ 25.72
US$ 21.34
US$ 23.39
US$ 21.82
US$ 21.04
